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Abstract
Background: Peutz-Jeghers syndrome (PJS) is an autosomal dominant hereditary disease
characterized by mucocutaneous pigmentation and gastrointestinal hamartomatous polyposis. The
germline mutations in the serine/threonine kinase 11 (STK11) gene have been shown to be
associated with the disease. Individuals with PJS are at increased risk for development of various
neoplasms. The aim of the present study was to characterize the genotype and phenotype of Czech
patients with PJS.
Methods: We examined genomic DNA of 8 individuals from five Czech families by sequencing
analysis of STK11 gene, covering its promotor region, the entire coding region and the splice-site
boundaries, and by multiplex ligation-dependent probe amplification (MLPA) assay designed for the
identification of large exonic deletions or duplications of STK11 gene.
Results: We found pathogenic mutations in STK11 gene in two families fulfilling the diagnostic
criteria of PJS and in one of three sporadic cases not complying with the criteria. The patient with
the frameshift mutation in STK11 gene developed aggressive gastric cancer. No other studied
proband has developed a carcinoma so far.
Conclusion: Our results showed that a germline mutation of STK11 gene can be found not only
in probands fulfilling the PJS diagnostic criteria, but also in some sporadic cases not complying with
the criteria. Moreover, we observed a new case of aggressive gastric cancer in a young patient with
a frameshift mutation of STK11 gene.
Background
Peutz-Jeghers syndrome (PJS; OMIM 175200) is an auto-
somal dominant disorder characterized by mucocutane-
ous pigmentation and gastrointestinal hamartomatous
polyposis with an increased risk of cancer [1-4]. The
cumulative risk of all cancers in PJS patients by the age of
60 years is 60% and is increased approximately by 8-fold
as compared to general population [5]. Histopathologi-
cally, polyps in PJS are characterized as hamartomas.
However, adenomatous changes may occur in polyps and
they can become malignant. In addition to an elevated
risk of gastrointestinal cancers, it has been described an
increased risk of cancer development at other sites, partic-
ularly in the breast, ovary, uterus, cervix, pancreas, lung
and testis [3,6-9]. Testicular sex cord and Sertoli cell
tumors, leading to sexual precocity and gynecomastia [10-
12], sex cord tumors with annular tubules and cervical
adenoma malignum [13] have also been reported.
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encodes a serine/threonine kinase and mapps to chromo-
some 19p13.3, acts as a tumor suppressor [4,14,15]. It
plays a role in the p53-dependent apoptosis pathway, in
the vascular endothelial growth factor signaling pathway
and in the polarization of epithelial cells [16-18].
About one-third of patients with PJS are diagnosed before
the age of 10 years and up to 60% cases develop their first
clinical manifestations until the third decade of life [19].
In most cases, initial symptoms are abdominal pain due
to intussusceptions, obstruction and gastrointestinal
bleeding with anemia [20,21]. A working definition of PJS
has been suggested by Giardiello [3], where for individu-
als with a histopathologically confirmed hamartoma, the
diagnosis of definite PJS requires two of the following
three findings: a family history consistent with the auto-
somal dominant inheritance, mucocutaneous hyperpig-
mentation, or small-bowel polyposis. Tomlinson and
Houlston [22] have modified the classification criteria for
PJS for individuals without a family history of PJS, in
whom the diagnosis depends on the presence of two or
more histologically verified Peutz-Jeghers-type hamar-
tomatous polyps.
There are some differential syndromes of PJS which could
be misdiagnosed. The pigmentation of the perioral region
is an external hallmark of PJS. It is not present in other
hamartomatous polyposis syndromes which include
Cowden syndrome (CS; OMIM 158350), Bannayan-
Riley-Ruvalcaba syndrome (BRRS; OMIM 153480) and
Juvenile polyposis syndrome (JPS; OMIM 174900).
Laugier-Hunziker syndrome (LHS) is another differential
diagnosis of PJS characterized by benign melanotic pig-
mentation of the oral cavity and lips, associated with spot-
ted macular pigmentation of the fingerprints and
longitudinal melanonychia. LHS is known to be a benign
disease without gastrointestinal polyposis and with no
systemic manifestation [23].
We report here a clinicopathological manifestation and
mutational analysis of STK11 gene in eight PJS individuals
from five unrelated Czech families.
Methods
Patients
Eight patients from five unrelated families were included
in the study (table 1). Four probands from two families
fulfilled and three sporadic cases did not fulfill criteria to
establish the diagnosis of definite PJS [3,22]. In one indi-
vidual, we made a presumptive diagnosis of PJS due to a
first-degree relative with PJS and the presence of mucocu-
taneous hyperpigmentation. All eight patients except one
(A-2) underwent endoscopic procedures to examine the
inspectable part of GIT.
Family A includes mother (case A-1) and her daughter
(case A-2).
Case A-1 was a 29-year-old female with negative family
history. The diagnosis of PJS was made at her 10 years of
age due to hyperpigmentation of the lips, buccal mucosa,
and perinasal region. X-ray examination of abdomen did
not reveal any polyp. The patient was free from any
abdominal symptoms. At her 24 years of age she under-
went gastroscopy because of dyspepsia lasting for a few
months. A rigid mucosa of the stomach was noted, but it
was histolopathologically negative. Sixteen months later
and seven months after giving birth, two hamartomatous
polyps 4.5 cm and 1.5 cm in diameter and multiple small
polyps 1–3 mm in diameter were found in her stomach.
Colonoscopy revealed tubulous adenoma, 3 cm in diam-
eter in her caecum. Enteroclysis did not show any pathol-
ogy of the small intestine. Later on, she has been followed
up every six months. During the follow up, a tubulovil-
lous adenoma from sigmoid colon and a hamartomatous
polyp from the transverse colon were removed, and at her
27 years of age, a well differentiated mucinous adenocar-
cinoma in her left inferior lung lobe was surgically
removed. One year later, during second gestation, adeno-
carcinoma of the stomach was found. The patient refused
termination of her pregnancy. Therefore, an operation
was performed without any previous neoadjuvant ther-
apy. Unfortunately, because of deterioration of her per-
formance state, premature birth was induced at the 30-th
week of the gestation. Three months later the patient died
of gastric cancer.
Table 1: Clinical manifestations
Family Case no Sex Age at onset/admission Initial symptoms/signs Histology of polyps Location Cancer Mutation
A *A-1 F 10 pigmentation hamartomatous throughout GIT lung, stomach +
A-2 F 2 pigmentation NA NA No +
B *B-1 F 36 pigmentation hamartomatous throughout GIT No +
*B-2 M 10 pigmentation hamartomatous throughout GIT No +
*B-3 M 6 pigmentation hamartomatous throughout GIT No +
C C-1 F 2 pigmentation adenomatous small intestine No +
D D-2 M 50 pigmentation hyperplastic colon No -
E E-3 M 10 pigmentation no polyps no polyps No -
NA – not analysed, GIT – gastrointestinal tract, * – fulfillment of PJS criteriaPage 2 of 8
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patches on the lower lip, which have been noted since her
2 years of age. Examination of her GIT was not performed.
The younger daughter, 4 years old, was not included in the
study. She was free of any symptoms typical for PJS.
Family B comprises mother (case B-1) and her two sons
(cases B-2 and B-3).
Case B-1, a 46-year-old female has presented with perioral
and buccal pigmentation, lasting since childhood. She
was found to have colonic and small intestinal hamar-
tomatous polyps already at 36 years of age. The polyps
from the stomach were histopathologically classified as
hyperplastic with diffuse mixed inflammatory infiltration
in stroma and focal epithelial metaplasia. Subsequently,
repeated colonoscopy and enteroscopy with polypectomy
have been performed. Eventually, total colectomy was
performed due to excessive polyposis and recurrent GIT
problems. Histopatholological examination of the polyps
did not reveal any malignancy. Her family history is miss-
ing.
Case B-2 represented a 17-year-old boy with perioral
brown pigmentation, mostly on the lips. At his 10 years of
age, hamartomatous polyps in small the intestine were
detected. Afterwards, he has been frequently examined by
gastroduodenoscopy and colonoscopy and polypecto-
mies have been performed. One polyp from the antrum of
the stomach, 3 mm in diameter, was classified as hyper-
plastic with stromal inflammation. Three colon polyps, 3
mm in diameter, showed the typical features of hamar-
tomatous lesions, branching strands of muscular tissue
and numerous cystic dilatations of the glandular lumens
of various sizes.
Case B-3, a 13-year-old boy, manifested with mucocuta-
neous brown to dark blue pigmentations on the lip,
mostly on the lower one. At his 6 years of age, rectal bleed-
ing due to a polyp, 55 × 35 × 20 mm, in the rectum was
noted. Histopathological examination of the polyp
showed a tubulovillous adenoma with mild dysplasia in
the superficial colonic epithelium. Later on, he has under-
gone frequent gastroduodenoscopies and colonoscopies
with polypectomies. Three polyps were classified as
hamartomatous and one as a tubulovillous adenoma with
low-grade dysplasia, 3 mm in diameter. All four polyps
were excised from the sigmoid colon.
The remaining cases (C-1, D-1 and E-1) were sporadic.
Case C-1, a 20-year-old female has presented brown to
dark blue pigmentations since her 2 years of age. At her 14
years of age, enteroclysis her small intestine showed one
adenomatous polyp. Frequent colonoscopies and ente-
roclysies with negative results have been performed. At
the time of the molecular analysis of her genomic DNA for
germline STK11 mutation, another capsule endoscopy
examination was performed. A few (less than ten) dimin-
utive polyps in the stomach and one polyp in the ileum
were found. The polyp from the ileum showed character-
istic histopathological features of adenoma. Polyps from
the stomach were not biopsied. Her family history was
negative.
Case D-1, a 50-year-old male with perioral and buccal pig-
mentation was found to have two hyperplastic polyps,
one in the sigmoideum and the other one in the colon
ascendens. Tubulovillous adenoma with low-grade dys-
plasia was excised from the ascending colon. The mother
of the patient had colon cancer in 72 years of age and his
father, a smoker, had lung cancer in 76 years of age. They
were without hyperpigmentation.
Case E-1, a 10-year-old boy, was referred because of peri-
oral and buccal pigmentation. Examination of his GIT did
not reveal any polyp. His parents and step-siblings are
without any PJS symptoms.
Genetic analysis
After receiving a written and signed informed consent, the
genomic DNA of the patients was isolated from blood leu-
kocytes using the Genomic DNA Purification Kit (Gentra
Systems, Minneapolis, MI, USA) according to manufac-
turer's guide. The genomic DNA was amplified using
intronic primers [24,25] flanking the nine exons and the
promoter region of STK11 gene. PCR reactions were per-
formed in a total volume of 30 μl containing 100 ng of
genomic DNA, 50 pmols of each primer, 0.2 mM of each
dNTP, 1 × Taq buffer containing 1.5 mM MgCl2 and 1 unit
of Taq polymerase (Fermentas, Vilnius, Lithuania). The
amplification was performed in 2720 Thermal cycler
(Applied Biosystems, Foster City, CA, USA) with the fol-
lowing protocol: an initial denaturation of 1 min at 95°C
was followed by 33 cycles of 1 min at 95°C, 1 min at
53°C, 1 min at 72°C, and a final extension step of 7 min
at 72°C. PCR products were purified using the SureClean
PCR purification kit (Bioline, London, UK). DNA
sequencing was performed using the purified PCR prod-
uct, the BigDye Terminator v3.1 Cycle Sequencing kit and
ABI 3130 Genetic Analyzer (both from Applied Biosys-
tem) according to the manufacturer's instructions.
Patients with negative results of DNA sequencing analysis
were further examined by means of the multiplex ligation-
dependent probe amplification (MLPA) method for the
identification of large exonic deletions or duplications,
using the P101-STK11 MLPA kit (MRC Holland, Amster-
dam, The Netherlands) and the following MLPA protocol
http://www.mlpa.com/WebForms/WebFormPage 3 of 8
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oFo/xHPnTgc|. Samples were run and data were analyzed
on ABI 3130 Genetic Analyzer in conjunction with Geno-
typer software (version 4.0; Applied Biosystems). Electro-
pherograms were evaluated by visual examination of peak
heights of the STK11 fragments in relation to the adjacent
control fragments and in comparison with external con-
trol DNA samples.
The study was conducted with approval by central ethical
committee of Ministry of Health, Czech Republic, in
accordance with the tenets of the Helsinki declaration.
Results and discussion
Excised polyps were histopathologically classified as
hamartomatous in the cases A-1, B-1, B-2, and B-3, as ade-
nomatous in the case C-1, and as hyperplastic in the case
D-1. Case E-1 was free of any polyps (Table 1). All studied
individuals had pigmentation of the lips and buccal
mucosa, while it was most visible in the children patients.
None of the probands had pigmentation of extremities. A
positive family history of cancer was only noted in the
case D-1. Mutation analysis revealed three different germ-
line mutations. In the family A, a germline mutation
(c.350dupT) in exon 2 (Fig. 1) was detected. This muta-
tion is predicted to introduce a frameshift at codon
Leu117, 46 novel amino acid residues, and a premature
termination codon (p.Leu117PhefsX46). It was found in
heterozygosity in both examined patients (A-1 and A-2).
Individuals from the family B (cases B-1, B-2, and B-3)
harboured deletion of a part of the promoter region and
exon 1 (Fig. 2). Case C-1 was a carrier of deletion of the
whole STK11 gene (Fig. 3). In the cases D-1 and E-1, we
have not revealed any variation of STK11 gene by using
the aforementioned methods.
PJS is a relatively very well characterized disorder with a
clear cut phenotype [22]. However, in sporadic cases, the
diagnosis of PJS may be uncertain. Although multiple
hamartomatous polyps of the GIT are pathognomonic of
the PJS, hyperplastic and adenomatous polyps are com-
monly present [17]. Recently, it has been reported that
STK11 deletions are not a rare cause of Peutz-Jeghers syn-
Sequencing chromatogram from the analysis of STK11 gene in the family A showing a duplication of thymine in the position c.350, leading t  a frameshi t and a premature stop codoFig re 1
Sequencing chromatogram from the analysis of STK11 gene in the family A showing a duplication of thymine in 
the position c.350, leading to a frameshift and a premature stop codon.Page 4 of 8
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Representative chromatogram from MLPA analysis of STK11 in the family B showing the relative reduction in the peak area of prob  hybr dising to ex n 1 and a part of the promotor region (arrows mark the deleted regions)Figure 2
Representative chromatogram from MLPA analysis of STK11 in the family B showing the relative reduction in 
the peak area of probes hybridising to exon 1 and a part of the promotor region (arrows mark the deleted 
regions).
Representative chromatogram from MLPA analysis of STK11 in the family C showing the relative reduction in the peak area of prob  hybr dising to ex ns 1–10 and the promotor regionFigure 3
Representative chromatogram from MLPA analysis of STK11 in the family C showing the relative reduction in 
the peak area of probes hybridising to exons 1–10 and the promotor region.
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[26,27]. There was no difference in the clinical phenotype
between the patients with point mutations or with large
genomic deletions [26]. However, the detailed phenotype
of patients with different types of mutations was not
reported.
Members of the family B (cases B-1, B-2, and B-3) had
almost uniform clinical symptoms with variable age of
onset of the first symptoms and detection of polyps. They
are carriers of a germline mutation (deletion of a part of
the promoter region and exon 1) of STK11. All three
affected individuals had mucocutaneous hyperpigmenta-
tion predominantly on the lips and on the buccal mucosa,
being the most prominent in the youngest patient (B-3)
and very pale in the mother (B-1). Sons of the latter
patient, i.e. the patients B-2 and B-3, were initially classi-
fied as PJS-suspected because of striking hyperpigmenta-
tion of the lips. Both of them are under careful
surveillance. A few endoscopic examinations of the GIT
have been performed so far, with polypectomy of hamar-
tomatous polyps. This confirmed the diagnosis of definite
PJS. Polyps were localized in the small intestine and
colon. No polyps were detected in the stomach.
Deletion of the promoter region and exon 1 was reported
in three independent studies in 12 PJS families overall
[26-28]. It could be a recurrent mutation, probably a con-
sequence of an unequal recombination mediated by
repetitive Alu (SINE elements) sequences. In accord with
UCSC Genome Browser, the region of chr19:1,129,999–
1,196,665, where STK11 gene is located, is rich for these
repetitive sequences, which can be involved in large chro-
mosome rearrangements. The implication of Alu repeti-
tive elements in unequal genomic recombinations were
described for another tumor suppressor gene, MSH2,
implicated in Lynch syndrome (HNPCC) [29].
We failed to find any variation of STK11 gene in sporadic
cases D-1 and E-1, which would explain their phenotype.
On the other hand, they did not fulfill criteria for the diag-
nosis of definite PJS [3,22]. We included these cases to the
study on the basis of the result from the case C-1. Espe-
cially in case E-1 PJS polyps could develop later on. Stud-
ies with more individuals not fulfilling PJS diagnostic
criteria were reported. None of the patients harboured a
germline mutation of STK11 gene [26,30]. Some studies
suggested there could be another locus responsible for PJS
phenotype [31,32]. Other authors stated according to
their results that another locus is unlikely and the causa-
tive variation could be in regulatory regions such as pro-
moter, enhancers, or splicing sites deep in introns, which
are not detectable by conventional methods [26,27,33].
The risk of developing various types of GIT cancers (in the
esophagus, stomach, small bowel and colon) was deter-
mined in several studies [3,5,7,8,34]. The cumulative risk
for stomach cancer was 29% [8]. Amos et al. noted that
gastric polyps are very common among individuals with
PJS [30]. However, they did not specify the proportion of
patients with a detectable PJS germline mutation and the
gastric polyps/cancer. There are several case-reports and
reviews reporting gastric cancer in PJS patients [3,20,35-
44]. In our group of probands, the case A-1 had developed
gastric cancer at 28 years of age and died one year later. No
genotype-phenotype correlations were published in PJS
patients with gastric cancer [7,30,33]. Konishi et al.
reviewed 103 PJS patients with malignancy from literature
and found out that the mean age of 8 cases with gastric
cancer was 31.2 years as compared to 39.7 years in duode-
nal carcinoma (9 cases), and 48 years in colorectal carci-
noma (13 cases). According to the literature and our
results we suppose that gastric cancer has very aggressive
course in some individuals with PJS and despite the very
frequent endoscopic examinations with relevant treat-
ment the next course is usually poor. Therefore, more
attention should be paid to patients with molecularly
confirmed PJS, especially those who have polyposis of the
stomach. It would be particularly interesting to find out if
there is a correlation between the genotype and pheno-
type in relation to the development of gastric cancer.
There have been only two reports dealing with gastric can-
cer in PJS patients and mutational analysis of STK11 gene
so far [24,43]. Shinmura et al. described two PJS females
(sisters) with gastric cancer in whom a STK11 germline
mutation (c.890delG) was identified [24]. Takahashi et al.
reported a 14-year-old girl with sporadic PJS and early-
onset gastric cancer harboring a frameshift
(c.757_758insT) STK11 mutation [43]. Similarly, as in
our family A, the mutations led to a truncated protein
lacking the kinase domain. These results suggest that the
truncation mutations leading to loss of STK11 kinase
domain could act in a dominant negative fashion and be
responsible of tumor development. Schumacher et al.
summarized clinical and mutational data from 132 PJS
cases (83 without and 49 with cancer) to find correlation
between the type/site of mutation and cancer. They pro-
posed two different mechanisms of tumor development.
One is based on the loss of STK11 functions due to trun-
cation mutations and subsequent LOH as a second hit.
This hypothesis is not in accord with findings of other
authors, where a second hit was not a requisite condition
for tumor development [24,43].
Conclusion
In summary, we found germline mutations of STK11 gene
in three families. One patient (C-1) with the germline
mutation did not fulfill the criteria for establishing the
diagnosis of PJS. Therefore, the variability in time of onset
of symptoms should be always kept in mind when estab-
lishing the diagnosis of PJS and managing this disease.Page 6 of 8
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